Location History:
- Torbay, NZ (1997 - 1999)
- Auckland, NZ (2000)
Company Filing History:
Years Active: 1997-2000
Title: The Innovative Mind of Graeme John Finlay
Introduction
Graeme John Finlay, an accomplished inventor based in Torbay, New Zealand, has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With three patents to his name, Finlay is dedicated to exploring new avenues for effective cancer therapies.
Latest Patents
Finlay's latest patents include groundbreaking work on Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents. These patents introduce a novel treatment schedule for administering N-2-(dimethylamino)ethyl acridine-4-carboxamide and related carboxamide anticancer drugs. This method strategically uses a divided-dose schedule, comprising multiple administrations at frequent intervals, such as every hour. By creating schedules that produce cyclic peaks and troughs in plasma levels, these compounds aim to overcome multidrug resistance found in various cancers, particularly in treatments for melanoma and advanced colon cancer.
Career Highlights
Working at Xenova Limited, Finlay operates at the intersection of research and practical application, where he applies his knowledge to develop new cancer treatments. His dedication and innovative spirit have established him as a vital contributor in his field.
Collaborations
Throughout his career, Finlay has collaborated with esteemed colleagues, including Bruce Charles Baguley and William Alexander Denny. These partnerships have fostered an environment of creativity and innovation, leading to advancements in cancer treatment methodologies.
Conclusion
Graeme John Finlay is a key figure in the realm of cancer research, with a clear focus on devising solutions to combat complex challenges in treatment. His patented inventions not only demonstrate his innovative prowess but also offer hope for improved therapeutic strategies for patients facing the daunting realities of cancer. Through his work at Xenova Limited and collaborative efforts with notable peers, Finlay continues to make strides in the fight against cancer.